NO930559L - Farmasoeytiske prerarater - Google Patents
Farmasoeytiske preraraterInfo
- Publication number
- NO930559L NO930559L NO93930559A NO930559A NO930559L NO 930559 L NO930559 L NO 930559L NO 93930559 A NO93930559 A NO 93930559A NO 930559 A NO930559 A NO 930559A NO 930559 L NO930559 L NO 930559L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- optionally substituted
- hydrogen
- phenyl
- cor
- Prior art date
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 125000004185 ester group Chemical group 0.000 abstract 2
- 125000001624 naphthyl group Chemical group 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 150000002825 nitriles Chemical class 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929203497A GB9203497D0 (en) | 1992-02-19 | 1992-02-19 | Pharmaceutical compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO930559D0 NO930559D0 (no) | 1993-02-17 |
| NO930559L true NO930559L (no) | 1993-08-20 |
| NO301712B1 NO301712B1 (no) | 1997-12-01 |
Family
ID=10710655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO930559A NO301712B1 (no) | 1992-02-19 | 1993-02-17 | Farmasöytisk aktive forbindelser, farmasöytiske midler inneholdende dem og deres anvendelse for fremstilling av farmasöytiske midler |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US5378699A (no) |
| EP (1) | EP0557075B1 (no) |
| JP (1) | JPH061784A (no) |
| KR (1) | KR100274103B1 (no) |
| CN (1) | CN1038680C (no) |
| AT (1) | ATE167675T1 (no) |
| AU (1) | AU664412B2 (no) |
| CA (1) | CA2089974A1 (no) |
| CZ (1) | CZ21793A3 (no) |
| DE (1) | DE69319262T2 (no) |
| DK (1) | DK0557075T3 (no) |
| ES (1) | ES2117097T3 (no) |
| FI (1) | FI930719A7 (no) |
| GB (1) | GB9203497D0 (no) |
| HU (1) | HUT63844A (no) |
| IL (1) | IL104739A (no) |
| MX (1) | MX9300840A (no) |
| MY (1) | MY109777A (no) |
| NO (1) | NO301712B1 (no) |
| NZ (1) | NZ245906A (no) |
| RU (1) | RU2083572C1 (no) |
| TW (1) | TW257760B (no) |
| ZA (1) | ZA931097B (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9203497D0 (en) * | 1992-02-19 | 1992-04-08 | Lilly Industries Ltd | Pharmaceutical compounds |
| GB9306062D0 (en) * | 1993-03-24 | 1993-05-12 | Lilly Industries Ltd | Pharmaceutical compounds |
| US5925673A (en) * | 1994-12-23 | 1999-07-20 | Alcon Laboratories, Inc. | Benzofurans and benzopyrans as cytoprotective agents |
| US5811453A (en) | 1994-12-23 | 1998-09-22 | Alcon Laboratories, Inc. | Viscoelastic compositions and methods of use |
| JPH10273467A (ja) * | 1997-01-29 | 1998-10-13 | Snow Brand Milk Prod Co Ltd | 新規テトラロン又はベンゾピラノン誘導体及びその製造方法 |
| FR2796312B1 (fr) * | 1999-07-16 | 2001-09-07 | Atofina | Catalyseur metallique supporte, sa preparation et ses applications dans la fabrication directe du peroxyde d'hydrogene |
| DE60333094D1 (de) * | 2002-04-17 | 2010-08-05 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren |
| US20040127519A1 (en) * | 2002-12-12 | 2004-07-01 | Pharmacia Corporation | Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors |
| US20040127511A1 (en) * | 2002-12-12 | 2004-07-01 | Pharmacia Corporation | Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| DE102004032418A1 (de) * | 2004-04-07 | 2005-10-27 | Bayer Cropscience Ag | Wirkstoffkombinationen mit insektiziden Eigenschaften |
| US10730885B1 (en) | 2019-04-30 | 2020-08-04 | King Saud University | Coumarin derivatives |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4243674A (en) * | 1978-06-12 | 1981-01-06 | Pfizer Inc. | 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore |
| US4931221A (en) * | 1988-12-30 | 1990-06-05 | Ppg Industries, Inc. | Photochromic spiropyran compounds |
| US5284868A (en) * | 1991-10-09 | 1994-02-08 | Eli Lilly And Company | Pharmaceutical compounds |
| GB9203497D0 (en) * | 1992-02-19 | 1992-04-08 | Lilly Industries Ltd | Pharmaceutical compounds |
| US5281619A (en) * | 1992-09-25 | 1994-01-25 | Eli Lilly And Company | Therapy for diabetic complications |
-
1992
- 1992-02-19 GB GB929203497A patent/GB9203497D0/en active Pending
-
1993
- 1993-02-02 TW TW082100682A patent/TW257760B/zh active
- 1993-02-05 US US08/014,016 patent/US5378699A/en not_active Expired - Fee Related
- 1993-02-15 NZ NZ245906A patent/NZ245906A/en unknown
- 1993-02-16 IL IL10473993A patent/IL104739A/xx not_active IP Right Cessation
- 1993-02-17 ZA ZA931097A patent/ZA931097B/xx unknown
- 1993-02-17 AU AU33099/93A patent/AU664412B2/en not_active Ceased
- 1993-02-17 MX MX9300840A patent/MX9300840A/es unknown
- 1993-02-17 ES ES93301156T patent/ES2117097T3/es not_active Expired - Lifetime
- 1993-02-17 KR KR1019930002170A patent/KR100274103B1/ko not_active Expired - Fee Related
- 1993-02-17 CZ CZ93217A patent/CZ21793A3/cs unknown
- 1993-02-17 AT AT93301156T patent/ATE167675T1/de not_active IP Right Cessation
- 1993-02-17 DK DK93301156T patent/DK0557075T3/da active
- 1993-02-17 DE DE69319262T patent/DE69319262T2/de not_active Expired - Fee Related
- 1993-02-17 MY MYPI93000265A patent/MY109777A/en unknown
- 1993-02-17 EP EP93301156A patent/EP0557075B1/en not_active Expired - Lifetime
- 1993-02-17 NO NO930559A patent/NO301712B1/no not_active IP Right Cessation
- 1993-02-18 HU HU9300446A patent/HUT63844A/hu unknown
- 1993-02-18 JP JP5029157A patent/JPH061784A/ja active Pending
- 1993-02-18 FI FI930719A patent/FI930719A7/fi unknown
- 1993-02-18 CN CN93102342A patent/CN1038680C/zh not_active Expired - Fee Related
- 1993-02-19 CA CA002089974A patent/CA2089974A1/en not_active Abandoned
- 1993-02-19 RU RU9393004522A patent/RU2083572C1/ru active
-
1994
- 1994-08-22 US US08/293,786 patent/US5663375A/en not_active Expired - Fee Related
-
1995
- 1995-06-05 US US08/461,342 patent/US5622987A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69319262T2 (de) | 1998-11-12 |
| IL104739A0 (en) | 1993-06-10 |
| IL104739A (en) | 1997-01-10 |
| US5663375A (en) | 1997-09-02 |
| US5378699A (en) | 1995-01-03 |
| KR100274103B1 (ko) | 2000-12-15 |
| CA2089974A1 (en) | 1993-08-20 |
| MX9300840A (es) | 1993-09-01 |
| US5622987A (en) | 1997-04-22 |
| AU3309993A (en) | 1993-08-26 |
| EP0557075A1 (en) | 1993-08-25 |
| CZ21793A3 (en) | 1994-02-16 |
| FI930719A0 (fi) | 1993-02-18 |
| HU9300446D0 (en) | 1993-05-28 |
| CN1038680C (zh) | 1998-06-10 |
| ZA931097B (en) | 1994-08-17 |
| EP0557075B1 (en) | 1998-06-24 |
| FI930719A7 (fi) | 1993-08-20 |
| HUT63844A (en) | 1993-10-28 |
| AU664412B2 (en) | 1995-11-16 |
| NZ245906A (en) | 1995-04-27 |
| MY109777A (en) | 1997-06-30 |
| CN1076696A (zh) | 1993-09-29 |
| DK0557075T3 (da) | 1998-12-14 |
| NO301712B1 (no) | 1997-12-01 |
| DE69319262D1 (de) | 1998-07-30 |
| TW257760B (no) | 1995-09-21 |
| ATE167675T1 (de) | 1998-07-15 |
| ES2117097T3 (es) | 1998-08-01 |
| KR930017887A (ko) | 1993-09-20 |
| JPH061784A (ja) | 1994-01-11 |
| GB9203497D0 (en) | 1992-04-08 |
| NO930559D0 (no) | 1993-02-17 |
| RU2083572C1 (ru) | 1997-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI941396L (fi) | Koostumuksia biologisesti aktiivisen TGF-valvottua vapauttamista varten | |
| NO930559D0 (no) | Farmasoeytiske prerarater | |
| DE69604714D1 (de) | Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen | |
| MX9202839A (es) | 4-aminoquinolinas y composiciones farmaceuticas de las mismas. | |
| DK246586D0 (da) | Laegemiddel paa basis af alfuzosin | |
| IT1246188B (it) | Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute. | |
| BR0214277A (pt) | Solvatos de paclitaxel | |
| EA200100983A1 (ru) | Производные 13-метилэритромицина | |
| HUT62281A (en) | Process for producing new naphto/1,2-b/pyran derivatives and pharmaceutical compositions comprising same as active ingredient | |
| EA200200119A1 (ru) | β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ | |
| NO975666D0 (no) | Pyrroldovater og medisinsk sammensetning | |
| DE60023647D1 (de) | Makrolide mit entzündungshemmender wirkung | |
| BR9107159A (pt) | Composicoes de sulfonamidas herbicidas protegidas | |
| MX9200146A (es) | Composiciones farmaceuticas deglutibles | |
| RU93004522A (ru) | Дигидронафтопирановые соединения, способ их получения и фармацевтическая композиция | |
| ATE274903T1 (de) | Antivirale mittel | |
| IT1270905B (it) | Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta | |
| TR27833A (tr) | Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu. | |
| YU82693A (sh) | Farmaceutske formulacije disulfonil metana i novi disulfonil metani | |
| FI922441A7 (fi) | Elsamisiini-A:n kemiallinen modifiointi 3'- ja/tai 4'-OH-ryhmissä | |
| DE69111530D1 (de) | Pyridincarbonsäure-Amid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
| FI925412A7 (fi) | Laktoneista johdettujen 2,2-dialkoksi-syklisten ortoestereiden valmist us | |
| IT8720701A0 (it) | Composizioni farmaceutiche adattivita' immunomodulante. | |
| DK0779075T3 (da) | Anvendelse af 3-alpha-hydroxy-5-alpha-androsta-16-en som lægemidler | |
| IT8942914A0 (it) | Giuoco di abilita'. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN AUGUST 2002 |